Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma

European Journal of Cancer Part A

Volumn 33, Issue 2, 1997, Pages 220-225

  Jelic S ^a   Kovcin V ^a   Milanovic N ^a   Babovic N ^a   Kreacic M ^a   Ristovic Z ^a   Vlajic M ^a   Filipovic Ljeskovic I ^a  

^a Institut za Onkologiju i Radiologiju   (Yugoslavia)

Author keywords

Chemotherapy; Cisplatin; Epirubicin; Soft tissue sarcoma

Indexed keywords

CISPLATIN; EPIRUBICIN;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOFT TISSUE SARCOMA; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CROSS-OVER STUDIES; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE;

EID: 0343052877     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00297-3     Document Type: Article

References (21)

1. Elias AD. Salvage therapy for soft tissue sarcomas. Semin Oncol 1994, 21 (Suppl 7), 76-81.
2. Mouridsen HT, Bastholt L, Somers R, et al. Adriamycin versus epirubicin in advanced soft tissue sarcomas: a randomized phase II/III study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Clin Oncol 1987, 23, 1477-1487.
3. Toma S, Palumbo R, Sogno G, Venturino A, Santi L. Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult advanced soft tissue sarcomas. Ann Oncol 1992, 3 (Suppl 2), S119-123.
4. Chevalier B, Montequet P, Facchini T, et al. Proc Ann Meet Am Soc Clin Oncol 1989, 8, 1256.
5. Carpano S, Vici P, Di Lauro L, et al. Treatment of advanced soft tissue sarcomas (STS) with high dose epirubicin (HD-EPI). Proc Ann Meet Am Soc Clin Oncol 1994, 1, A1680.
6. Lopez M, Carpano S, D'Aprile M, et al. High-dose epirubicin (HD-EPI) +/-Ionidamine (LND) in adult patients with advanced sarcomas. Proc Ann Meet Am Soc Clin Oncol 1992, 11, A1452.
7. Frustaci S, Bonadonna A, Favaro D, et al. Effectiveness of intensive chemotherapy (ICT) in metastatic soft tissue sarcoma. Proc Ann Meet Am Soc Clin Oncol 1994, 13, A1650.
8. Chevalier B, Leyvraz S, Olivier JP, Fargeot P, Facchini T, Vo Van ML. Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study. Cancer Invest 1993, 11(2), 135-139.
9. Toma S, Palumbo R, Canavese G, et al. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas. Cancer Chemother Pharmacol 1993, 31 (Suppl 2), S222-227.
10. Jelić S, Vuletić L, Milanović N, Tomašević Z, Kovčin V. High-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma. Tumori 1990, 76, 467-471.
11. Jelić S, Vuletić L. High doses of epirubicin in the treatment of advanced soft tissue sarcomas. Acta Oncologica 1991, 12(6), 541-546.
12. Jelić S, Kovčin V, Vuletić L, et al. Study of some cardiac toxicity parameters during high-dose epirubicin treatment of advanced soft tissue sarcomas. Onkol Arch 1993, 1(1), 19-22.
13. Milles AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981, 47, 207-214.
14. Pinedo HM, Kenis Y. Chemotherapy of advanced soft tissue sarcoma in adults. Cancer Treat Rev 1977, 4, 67-86.
15. Sauer H, Mair W, Fink U, Ruckle H, Mjaaland I, Wilmanns W. Polychemotherapie fortgeschrittener weichteilsarkome mit 4′-EPI-Doxorubicin (4′/-EPI-DX) und Cisplatin (DDP). Onkologie 1986, 9 (Suppl 1), 24-28.
16. Rouesse J, Sevin D, Le Chevalier T, et al. Initial chemotherapy in locally advanced soft-tissue sarcoma. Colloq INSERM 1986, 137, 567-572.
17. Kempf RA, Irwin LE, Menendez LR, et al. Intra-arterial cisplatin for extremity soft tissue and bone sarcoma in adults and teenagers - a limb salvage protocol. Proc Ann Meet Am Soc Clin Oncol 1988, 7, A1070.
18. Sordillo PP, Magill GB, Brenner J, Cheng EW, Dosik M, Yagoda A. Cisplatin. A phase II evaluation in previously untreated patients with soft tissue sarcomas. Cancer 1987, 59(5), 884-886.
19. Raney RB Jr. Inefficacy of cisplatin and etoposide as salvage therapy for children with recurrent or unresponsive soft tissue sarcoma. Cancer Treat Rep 1987, 71(4), 407-408.
20. Budd GT, Bolarzan S, Mortimer J, Fletcher W (SWOG). High dose cisplatin (CDDP) for advanced sarcomas. Proc Ann Meet Am Soc Clin Oncol 1987, 6, 536.
21. Lopez M, Carpano S, Di Lauro L, Vici P, Conti EM. Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas. Oncology 1991, 48(3), 230-233.